Message #76 From:
NewsBot Date: December 15, 2006 01:01:00 PM
ALNY News Alnylam Announces Closing of Common Stock Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today the closing
of its public offering of 4,700,000 shares of common stock. Net proceeds
to the company are approximately $101 million. The offering was
underwritten by Banc of America Securities LLC.
Alnylam is a leading biopharmaceutical company developing novel
therapeutics based on RNA interference, or RNAi.
